Detalhe da pesquisa
1.
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2.
ERJ Open Res
; 9(5)2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37868151
2.
Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.
Clin Res Hepatol Gastroenterol
; 45(2): 101564, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740477